Related Experiment Video
Updated: Jul 15, 2026
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
M A Gillman1, F J Lichtigfeld, T N Young
1S.A.Brain Research Institute, 6 Campbell, Johannesburg, Gauteng, South Africa, 2090. mag@iafrica.com
The Cochrane Database of Systematic Reviews
|April 20, 2007
Summary
Psychotropic analgesic nitrous oxide (PAN) may effectively treat mild to moderate alcohol withdrawal symptoms, improving patient recovery. Further research is needed to confirm PAN
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Medicine
Background:
- Alcoholism affects 5-10% of the global population, leading to severe alcohol-related diseases.
- Alcohol withdrawal syndrome is a critical consequence of alcohol dependence.
- Benzodiazepines are the standard treatment, but psychotropic analgesic nitrous oxide (PAN) offers an alternative.
Purpose of the Study:
- To evaluate the efficacy of psychotropic analgesic nitrous oxide (PAN) in managing alcohol withdrawal states.
- To compare PAN treatment with traditional benzodiazepine and oxygen regimens.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) identified through comprehensive database searches (Cochrane, MEDLINE, EMBASE, CINAHL) up to May 2005.
- Inclusion criteria focused on voluntary participants with alcohol dependence, comparing PAN to oxygen and/or benzodiazepines.
- Two independent reviewers assessed trial quality and extracted data.
Main Results:
- Five RCTs involving 212 participants were analyzed.
- PAN demonstrated significant improvement in withdrawal symptoms (RR 1.35; 95% CI 1.01 to 1.79) and psychomotor function (WMD -8.71; 95% CI -13.71 to -3.71).
- No significant differences in depression or anxiety were observed; no serious adverse effects were reported for any treatment.
Conclusions:
- PAN shows promise as an effective treatment for mild to moderate alcohol withdrawal, potentially accelerating patient recovery.
- The rapid therapeutic effect and minimal sedation of PAN may facilitate quicker entry into psychological treatment phases.
- Further high-quality trials with larger sample sizes are recommended to confirm efficacy, assess adverse effects, and explore cost-effectiveness.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:28Depressants
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...